Your browser doesn't support javascript.
loading
ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe.
Bayle, A; Bonastre, J; Chaltiel, D; Latino, N; Rouleau, E; Peters, S; Galotti, M; Bricalli, G; Besse, B; Giuliani, R.
Affiliation
  • Bayle A; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, Villejuif; Université Paris Saclay, Université Paris-Sud, Faculté de Médicine, Le Kremlin Bicêtre, Paris; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay,
  • Bonastre J; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France.
  • Chaltiel D; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France.
  • Latino N; European Society for Medical Oncology (ESMO), Lugano, Switzerland.
  • Rouleau E; Department of Medical Biology and Pathology, Tumor Genetic Lab, Gustave Roussy, Villejuif; INSERM UMR 981, Gustave Roussy, Villejuif, France.
  • Peters S; European Society for Medical Oncology (ESMO), Lugano, Switzerland; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Galotti M; European Society for Medical Oncology (ESMO), Lugano, Switzerland.
  • Bricalli G; European Society for Medical Oncology (ESMO), Lugano, Switzerland.
  • Besse B; Université Paris Saclay, Université Paris-Sud, Faculté de Médicine, Le Kremlin Bicêtre, Paris; Paris-Saclay University, Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
  • Giuliani R; European Society for Medical Oncology (ESMO), Lugano, Switzerland; Guy's and St Thomas NHS Foundation Trust, London, UK.
Ann Oncol ; 34(10): 934-945, 2023 10.
Article in En | MEDLINE | ID: mdl-37406812

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Limits: Humans Country/Region as subject: Europa Language: En Journal: Ann Oncol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Limits: Humans Country/Region as subject: Europa Language: En Journal: Ann Oncol Year: 2023 Document type: Article